Literature DB >> 3881675

Suppression of thyrotropin in the low-thyroxine state of severe nonthyroidal illness.

R E Wehmann, R I Gregerman, W H Burns, R Saral, G W Santos.   

Abstract

In a prospective study, we assessed the role of thyrotropin in the development of the low-thyroxine state that is associated with severe illness. We measured the serum thyrotropin and thyroid hormone concentrations longitudinally in 35 patients with hematopoietic cancer or aplastic anemia who were treated by bone-marrow transplantation. In 19 patients thyroxine declined sharply after bone-marrow transplantation and was associated with a reduction of the serum thyrotropin in the 17 patients tested, often to levels below the normal range. The serum triiodothyronine level, free thyroxine index, and free thyroxine level also declined in these patients. In the patients who recovered, clinical improvement was accompanied by the return of thyrotropin and thyroid hormone concentrations to their pretreatment ranges. These and related findings suggest that the low-thyroxine state of severe illness is the result of several events, one of which is failure of the normal negative-feedback control of the pituitary-thyroid axis due to illness-associated, decreased secretion of thyrotropin. The notion that such patients are "euthyroid" must be questioned, but the possible value of thyroid hormone-replacement therapy in these circumstances remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881675     DOI: 10.1056/NEJM198502283120904

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  22 in total

1.  Disturbance of plasma thyroid hormone levels after experimental liver transplantation. Is there an association with primary graft nonfunction?

Authors:  C D Oakland; L Darge; R Hickman
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

2.  Endocrine abnormalities in severe traumatic brain injury--a cue to prognosis in severe craniocerebral trauma?

Authors:  J M Hackl; M Gottardis; C Wieser; E Rumpl; C Stadler; S Schwarz; R Monkayo
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

3.  Early-onset thyrotoxicosis after unrelated cord blood transplantation for acute myelogenous leukemia.

Authors:  Takaaki Konuma; Akira Tomonari; Satoshi Takahashi; Jun Ooi; Nobuhiro Tsukada; Toshiki Yamada; Hiroyuki Sato; Hitomi Nagayama; Tohru Iseki; Arinobu Tojo; Shigetaka Asano
Journal:  Int J Hematol       Date:  2006-05       Impact factor: 2.490

Review 4.  The immune system as a regulator of thyroid hormone activity.

Authors:  John R Klein
Journal:  Exp Biol Med (Maywood)       Date:  2006-03

Review 5.  Thyrotoxicosis in a patient with multiple trauma: value of "AMPLE" history taking.

Authors:  J Fitz-Henry; B Riley
Journal:  BMJ       Date:  1996-10-19

Review 6.  Hormonal changes in non-endocrine disease.

Authors:  C G Semple
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

7.  'Apathetic' thyrotoxicosis presenting with hypercalcaemia and spurious normalization of serum thyroid hormone levels.

Authors:  S H Ralston; W D Fraser; M Soukop; J H McKillop
Journal:  Postgrad Med J       Date:  1987-04       Impact factor: 2.401

8.  The secretion of human growth hormone stimulated by human growth hormone releasing factor following severe cranio-cerebral trauma.

Authors:  M Gottardis; C Nigitsch; E Schmutzhard; M Neumann; C Putensen; J M Hackl; W Koller
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

9.  Do acute diseases transiently impair anterior pituitary function in patients over the age of 75? A longitudinal study of the TRH test and basal gonadotrophin levels.

Authors:  M Impallomeni; B M Kaufman; A J Palmer
Journal:  Postgrad Med J       Date:  1994-02       Impact factor: 2.401

10.  Serum thyroid hormone profile in critically Ill children.

Authors:  Jyoti Chandrashekar Suvarna; Chandrashekar N Fande
Journal:  Indian J Pediatr       Date:  2009-12       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.